Current evidence suggests that combination therapy is not associated with an increased risk of adverse events compared with monotherapy [26, 27], although patients remain susceptible to the characteristic drug-specific side effects of each medication class
GLP-1, or glucagon-like peptide-1, is a gut hormone released after eating that helps regulate appetite, insulin secretion, and blood sugar levels
(Its worth noting that despite BMI being a qualifying factor for a prescription, it is widely considered an outdated method for assessing physical health.) Recently my friends and I swapped personal examples in our group chat
Neurochem Res 31:12631269 Koh S-H, Lee SM, Kim HY, Lee K-Y, Lee YJ, Kim H-T, Kim J, Kim M-H, Hwang MS, Song C (2006) The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice